Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.

The California Plasma Coalition (CalPlasma) today launched a statewide campaign to raise awareness of the vital role that plasma donations play in saving lives of Californians and patients around the ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

She was admitted to the QEH in early July 2024, and was diagnosed with acquired haemophilia. She remained in hospital and died there on September 3. Their children, David Morley and Sally ...

Bluebird acquired the platform when it bought Precision ... VIII replacement product called NovoEight, part of a broader haemophilia franchise that accounted for a little under 9% of the company ...

When Sanofi acquired Bioverativ forecasts for BIVV001 were that it could become a $2 billion product, although the haemophilia A market has evolved in the meantime. The launch of Hemlibra ...

Sam Smith explores how more than a thousand haemophiliacs in the UK acquired HIV through their treatment - in what's come to be known as the contaminated blood scandal.

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The growth was driven by strong demand for new medicines, which offset ...